EZH2 often plays a role as a cancer promoter in gliomas, primarily regulating gene expression at the epigenetic level by catalyzing trimethylation of lysine 27 on histone H3 (H3K27me3) [19, 20]. The gene discussed is EZH2; the disease is glioma.